Effect of Saccharomyces cerevisiae var. Boulardii and β-galactomannan oligosaccharide on porcine intestinal epithelial and dendritic cells challenged in vitro with Escherichia coli F4 (K88) by Badia, Roger et al.
RESEARCH Open Access
Effect of Saccharomyces cerevisiae var. Boulardii
and b-galactomannan oligosaccharide on porcine
intestinal epithelial and dendritic cells challenged
in vitro with Escherichia coli F4 (K88)
Roger Badia
1,3*, Galliano Zanello
2, Claire Chevaleyre
2, Rosil Lizardo
1, François Meurens
2, Paz Martínez
3,
Joaquim Brufau
1* and Henri Salmon
2
Abstract
Probiotic and prebiotics, often called “immune-enhancing” feed additives, are believed to deal with pathogens,
preventing the need of an immune response and reducing tissue damage. In this study, we investigated if a
recently developed b-galactomannan (bGM) had a similar protective role compared to Saccharomyces cerevisiae var.
Boulardii (Scb), a proven probiotic, in the context of enterotoxigenic Escherichia coli (ETEC) infection. ETEC causes
inflammation, diarrhea and intestinal damage in piglets, resulting in large economic loses worldwide. We observed
that Scb and bGM products inhibited in vitro adhesion of ETEC on cell surface of porcine intestinal IPI-2I cells. Our
data showed that Scb and bGM decreased the mRNA ETEC-induced gene expression of pro-inflammatory cytokines
TNF-a, IL-6, GM-CSF and chemokines CCL2, CCL20 and CXCL8 on intestinal IPI-2I. Furthermore, we investigated the
putative immunomodulatory role of Scb and bGM on porcine monocyte-derived dendritic cells (DCs) per se and
under infection conditions. We observed a slight up-regulation of mRNA for TNF-a and CCR7 receptor after co-
incubation of DC with Scb and bGM. However, no differences were found in DC activation upon ETEC infection
and Scb or bGM co-culture. Therefore, our results indicate that, similar to probiotic Scb, prebiotic bGM may protect
intestinal epithelial cells against intestinal pathogens. Finally, although these products may modulate DC activation,
their effect under ETEC challenge conditions remains to be elucidated.
Introduction
The infection by enterotoxigenic Escherichia coli (ETEC)
is one on the most important causes of neonatal and post-
weaning diarrhea (PWD) in piglets. ETEC causes signifi-
cant morbidity and mortality, resulting in a large eco-
nomic loses in the porcine industry. One of the most
common ETEC in swine is serotype 0149 which carries
the K88 (F4) adhesin that enables the attachment of the
bacteria to the intestinal epithelium. ETEC colonizes
ileum [1,2], penetrate the epithelium and its pathogenesis
is ascribed to the production of different combination of
heat-labile (LT) and heat-stable (ST) enterotoxins [3,4].
Antibiotic growth promoters (AGPs) have been long
used in animal feeding to prevent neonatal and PWD in
piglets. The use of AGPs increases the prevalence of
bacteria resistant to antibiotics in farm animals and con-
stitutes a potential risk of antibiotic resistance transfer-
ence to human pathogenic bacteria, following to
consumption of animal derived products [5]. The
European ban of AGPs in animal production (EC 1831/
2003) increased the need to develop new alternatives [6]
to control and prevent animal colonization by patho-
genic bacteria and somehow guarantee animal welfare
and food safety.
Probiotics and prebiotics are interesting alternatives to
AGP for animal feeding. They are believed to control
pathogenic bacteria colonization and to enhance the
mucosal immune system, resulting in a decreased patho-
genic load and improving animal welfare [7]. The yeast
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any medium, provided the original work is properly cited.Saccharomyces cerevisiae var. Boulardii (Scb) is a well-
known probiotic with proven effects for the treatment
and prevention of gastrointestinal diseases (see [8] for
review). Typically, between 30-60% of Saccharomyces
yeast wall is composed by polysaccharides [9] and speci-
fically mannose and galactose mannans represent
respectively more than 50 μg/mg of yeast dry mass [10].
Our center (Institut de Recerca i Tecnologia Agroali-
mentàries, IRTA) developed a highly rich b-galactoman-
nan prebiotic (bGM) from the carob bean of the
Ceratonia silliqua tree that as non-digestible food pre-
biotic ingredient may beneficially affect the host.
Intestinal epithelial cells (IECs) and dendritic cells (DC)
of the gut are crucial for maintaining immunological toler-
ance to environmental, food antigens and commensal bac-
teria, but also to develop strong responses to invading
pathogens when required [11,12]. Recent studies have
demonstrated that IECs are far from being a simple physi-
cal barrier to the external environment. Pathogen asso-
ciated molecular patterns (PAMPS) are recognized by
Pattern recognition receptors (PRRs), such as Toll-like
receptors (TLRs), expressed on IECs membranes [13],
leading to the activation of proinflammatory pathways, as
nuclear factor-B (NF--B) and activator protein 1 (AP1),
related to cytokines and chemokines that coordinate the
innate immune response [14].
Our work intended to establish an in vitro screening
of an already known probiotic (Scb) and new developed
prebiotic (bGM) to promote their use in animal feeding.
First, we focused on antimicrobial activity and bacterial
adhesion studies of these products on the IECs and how
they may enhance an effective maintenance of the
intestinal barrier. Furthermore, we studied their ability
to modulate DCs which are pivotal for linking innate
and adaptive immune response against pathogens. We
were especially interested in the role of both cells types
in cytokine and chemokine networks that regulate the
homeostasis in the gastrointestinal tract [15].
Materials and methods
Intestinal epithelial cell culture
The porcine small intestine epithelial cell line IPI-2I
(ECACC 93100622) was established from the ileum of
an adult boar (SLAd/d haplotype) [16]. IPI-2I cells were
maintained in DMEM (Invitrogen, Cergy Pontoise,
France) supplemented with 10% FCS (Sigma-Aldrich,
Saint-Quentin, France), 4 mM L-glutamine (Invitrogen),
insulin 10 μg/mL (Sigma-Aldrich), 100 U/mL penicillin
and 100 μg/mL streptomycin (Invitrogen). In all experi-
ments, cells were cultured in 6-well plates (Falcon) to
confluence. Before the addition of pre/probiotics and/or
infection, cells were washed three times to remove anti-
biotics and culture media was replaced by DMEM
media (Invitrogen) containing 4 mM L-glutamine (Invi-
trogen) and insulin 10 μg/mL (Sigma-Aldrich). Cells
were used between passages 30-50 and periodically
tested to avoid Mycoplasma contamination (MycoAlert
®
Mycoplasma Detection Kit, Lonza).
Probiotic and prebiotic preparation
Lyophilized Saccharomyces cerevisiae var. Boulardii (Scb,
Biocodex, Laboratoires Montrouge, France) was rehy-
drated with 10 mL of DMEM and incubated for 30 min at
30°C. Then, yeast was counted with a Neubauer cell coun-
ter and methyl blue to exclude non-viable yeast. The yeast
was added to the selected wells (multiplicity of infection,
MOI = 3) and incubated overnight at 37°C and 10% CO2.
Commercially prebiotic Salmosan
® (patent WO2009/
144070 A2, licensed by Industrial Técnica Pecuaria,
ITPSA, Barcelona, Spain) contains more than 98% of b-
galactomannan (bGM) which is a b-(1-4)-mannose back-
bone with branched galactose molecules (ratio galactose:
mannose 1:4) [17]. Commercially prebiotic Salmosan
®
also contain less than 1% of other polysaccharides such
as xylose, fructose, arabinose, glucose, galactosamine and
fucose derived from the carob bean gum and the seed of
the Ceratonia silliqua tree. This is product is industrially
treated to become soluble in gut. bGM is was diluted in
DMEM (1 mg/mL), homogenized and incubated 30 min
at 37°C. Immediately before the infection, bGM was
added to each well at 10 μg/mL.
Host cell-pathogen assay
Two pathogenic E.coli K88 (ETEC) strains were used in
the host-pathogen assays. Initially, ETEC 56190 F4
+
(K88ad, O8:K87:H19, LT
+ and STb
+) from INRA collec-
tion was used for cytokine and chemokine mRNA
assays. For adhesion assays and cytokine protein secre-
tion we used strain ETEC GN1034 F4
+ (K88
+,L T
+,S T a
+ and STb
+) provided by Dr Ignacio Badiola (Centre de
Recerca en Sanitat Animal,CReSA, IRTA-UAB, Spain)
which was more adherent to IPI-2I cells [18]. Both
ETEC strains were preserved frozen in glycerol 15% at
-80°C until their use. Before infection, 50 μLo fE T E C
were added to 20 mL of Luria-Bertrani media (LB) and
cultured for 3-4 h at 37°C with 180 rpm rotational agita-
tion (Multitron HT, Infors). For the infection, ETEC was
used at exponential growth phase by determination of
absorbance at 600 nm. ETEC was used at MOI = 10,
previously determined by cytotoxic lactate dehydrogen-
ase activity assay (Cytotoxicity Detection Kit Plus LDH,
Roche). In vitro challenge lasted 3 h for gene expression
and bacterial adherence studies or 24 h for supernatant
cytokine determination. After host cell-pathogen co-cul-
ture, cells or supernatants were respectively sampled
and stored until their analysis.
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Protective effect of Scb and bGM was assessed by the
a d h e r e n c ea s s a yo fE T E Co nI P I - 2 Ic e l l s .P r o t o c o lw a s
previously described by [19]. After the host-pathogen
assay, supernatant was removed and cells were washed
twice with sterile PBS to eliminate all non-adhered bac-
teria. Then, cells were homogenized with 1 mL of 0.1%
Triton × 100 (Sigma-Aldrich) for 15 min. This solution
was serially diluted in PBS and 100 μL (dilution 1 × 10
-
3) was plated in LB-Agar Petri dishes for 24 h at 37°C to
enumerate the number of colony former units (CFU).
The ability of ETEC GN1034 strain to adhere to IPI-2I
cells was calculated as follows:
Adherence (%)=
Adhered ETEC to IECs
Total ETEC added/well
× 100
To determine adherence differences between experi-
mental treatments, the relative percentage of adherence
was calculated using next equation:
Relative adherence (%)=
CFU/ml treatment
CFU/ml control infection
× 100
Isolation of mRNA and cDNA synthesis
Total RNA was isolated from homogenized cells using
Trizol reagent (Invitrogen) and RNeasy MiniKit (Qiagen,
Courtaboeuf, France). Then, RNA samples were treated
with DNase I Amp Grade (Invitrogen) (1 U/μgo fR N A ) .
RNA concentration was determined by measuring optical
density at 260 nm (OD260) and the RNA quality was
assessed by calculating OD260/OD280 ratio and by capil-
lary electrophoresis (Agilent 2100 Bioanalyzer, Agilent
Technologies Inc., Santa-Clara, USA). A total of 1 μgo f
RNA was incubated in a final volume of 20 μL containing
2 μL dNTP (0.25 mM final each), 1.3 μL oligodT (133
pmoles/μL), 0.8 μL MuMLV reverse transcriptase (25 U/
μL), 4 μL 5 × MuMLV buffer (Eurogentec, Liège, Belgium)
and 1.9 μL of ultra-pure water (Gibco, Paisley, Scotland).
The reaction was maintained for 90 min at 37°C and then
heat-inactivated at 93°C for 5 min. The generated cDNA
was stored at -80°C.
Messenger RNA expression analysis using quantitative
real-time PCR
Many mRNA and primer sequences have already been
identified in pigs [20-22]. When genes were not described
in this species, tBLASTn searches of the GenBank and
PEDEblast ESTs databases, using known human and
murine amino acid sequences, have been performed.
These primers (purchased from Eurogentec) allowed the
mRNA expression analysis of various genes involved in
the innate immune response (Table 1). The qPCR was
performed using cDNA synthesized as previously
described [23]. Diluted cDNA (10X) was combined with
primer/probe sets and IQ SYBR Green Supermix (Bio-
Rad, Hercules, CA, USA) according to the manufacturer’s
recommendations. The qPCR conditions were 98°C for
30 s, followed by 37 cycles with denaturation at 95°C for
15 s and annealing/elongation for 30 s (annealing tem-
perature, Table 1). Real time assays were run on a Bio-
Rad Chromo4 (Bio-Rad). The specificity of the qPCR
reactions was assessed by analyzing the melting curves of
the products and size verification of the amplicons. Each
qPCR reaction included a reverse transcription negative
control (RNA sample without reverse transcriptase) to
check the absence of genomic DNA. To minimize sample
variation, we used identical number of cells and high
quality RNA. Samples were normalized internally using
simultaneously the average cycle threshold (Cq)o f
Hypoxanthine PhosphoRibosyl-Transferase 1 (HPRT-1),
Ribosomal Protein L 19 (RPL-19) and Tata Box Binding
Protein 1 (TBP-1) [24] as references in each sample to
avoid any artifact of variation in the target gene. These
genes were selected as the reference genes because of
their low variation between samples. A standard curve
was generated using diluted cDNA. The correlation coef-
ficients of the standard curves were > 0.995 and the con-
centrations of the test samples were calculated from the
standard curves, according to the formula y = -M × Cq +
B, where M is the slope of the curve, Cq the point during
the exponential phase of amplification in which the fluor-
escent signal is first recorded as being statistically signifi-
cant above background and B the y-axis intercept. Cq
values were used to calculate the qPCR efficiency from
the given slope according to the equation: qPCR effi-
ciency = (10[-1/M] - 1) × 100. All qPCRs displayed effi-
ciency between 90% and 110%. Expression data are
expressed as relative values after Genex macro-analysis
with three reference genes (Bio-Rad, Hercules, USA) [25].
Determination of cytokine production
Cytokine protein determination in the culture superna-
tant was performed by enzyme-linked immunosorbent
assays (ELISAs). Host cell-pathogen assay was per-
formed as described above but to avoid bacterial over-
growth Gentamycin 100 μg/mL (Sigma-Aldrich) was
added to each well. Cell culture supernatant was col-
lected after 24 h and stored at -80°C until analysis.
Swine IL-6 and CXCL8 DuoSet ELISA from R&D Sys-
tems (Vitro SP, Spain) were used according to manufac-
turer’s recommendations.
Isolation of peripheral blood monocytes and
differentiation of monocyte derived dendritic cells
Blood samples were obtained from 6 to 12-month old
large white pigs at the slaughter house. Blood was col-
lected into heparinised tubes and followed the protocol
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Briefly, peripheral blood monocytes (PBMC) were iso-
lated by centrifugation (1000 g ×3 0m i n )o v e rF i c o l l
(d = 1.077, Histopaque, Sigma-Aldrich). Red blood lys-
ing solution (Sigma-Aldrich) was used to remove
remaining erythrocytes. Then, cells were resuspended in
RPMI glutamax (Gibco, Invitrogen) containing 2.5%
FBS, 1% Pen/strep and 50 μMo f2 - b-mercaptoethanol
(Sigma-Aldrich). Next, 150 × 10
6 cells/20 mL were pla-
ted in 150 cm
2 cellBind flasks (Corning, Afora, Spain)
and incubated for 30 min at 37°C and 5% CO2.T h e n ,
flasks were washed with RPMI to remove all non-adher-
ent cells (lymphocytes). To induce differentiation,
monocytes were cultured with RPMI glutamax media
containing 1% Pen/Strep antibiotic, 10% FBS, 50 μM b-
mercaptoethanol and swine recombinant cytokines IL4
(100 ng/mL) and GM-CSF (20 ng/mL) (Biosource, Invi-
trogen) for 6 days at 37°C and 5% CO2. On day 3, fresh
medium and cytokines were added at the same concen-
trations as previously.
Dendritic cell phenotyping
After 6 days of culture, cells showed typical DC cell
morphology, defined by large cytoplasmic cell mass and
long dendrites. In addition, DCs were characterised as
CD172a
+ (SWC3), SLA class II-DQ
+, SLA class II-DR
+,
CD80/86
+,C D 1 4
mod and CD11R1
-. Antibodies for cell
surface markers CD172a/SWC3, SLA class II -DQ, SLA
class II-DR and CD11R1 were provided by Dr J. Domín-
guez (INIA, Madrid, Spain). Antibody for CD14 deter-
mination was purchased from Acris Antibodies
(AntibodyBCN, Barcelona, Spain) and for CD80/CD86
we used recombinant human Cytotoxic T-lymphocyte
associated molecule-4/Fc fusion protein (CTLA4-Fc
IgG1, Invitrogen). The FITC-conjugated anti-human
immunoglobulin IgG1 or Zenon tricolor mouse IgG1
and IgG2a labelling kits (Invitrogen) were used for
detection by flow cytometry (FACSCanto™ using FACS-
Diva™ s o f t w a r e ;B DB i o s c i e n c e s ,S a nJ o s é ,C a l i f o r n i a ,
USA).
Pathogen induced dendritic cell activation
After 6 days of culture, DCs were recovered and
adjusted to 5 × 10
5-1×1 0
6 DC/well into 24-well plates.
Then, DCs were incubated with Scb (MOI = 3) or bGM
(10 μg/mL) and challenged with ETEC (MOI = 5). After
3 h of exposure, supernatants were discarded and cells
were collected in Trizol reagent. Isolation of DCs
mRNA and gene expression studies was performed as
described above.
Statistical analysis
All statistical analyses were performed using PROC
GLM by SAS Software version 9.1.3 (SAS institute,
Carey, NC, USA). Means for adhesion percentages,
mRNA and protein secretion were considered in a
Table 1 Primer sequences and annealing temperatures of primer sets (°C), expected PCR fragment sizes (bp) and
associated references.
Genes Sense Antisense T° Annealing Product length Accession
Number
Reference
APRIL TGCTCACCCGTAAACAGAAG TAAACTCCAGCATCCCAGAC 60 172 EST BP170456 [21]
BAFF GAGAGCAGCTCCATTCAAAG GCATGCCACTGTCTGCAATC 60 103 NM_001097498 [21]
CCL2 GTCACCAGCAGCAAGTGTC CCAGGTGGCTTATGGAGTC 60 112 EF107669 [43]
CCL17 TGCTGCTCCTGGTTGCTCTC ATGGCGTCCCTGGTACACTC 67 169 EST DB794536 [20]
CCL20 GCTCCTGGCTGCTTTGATGTC CATTGGCGAGCTGCTGTGTG 66 146 NM 001024589 [21]
CCR7 AGGAGGCTCAAGACCATGAC GATGCCGAAGATGAGTTTGC 62 147 AB090356
CXCL2 TGCTGCTCCTGCTTCTAGTG TGGCTATGACTTCCGTTTGG 60 171 NM_001001861 [21]
GM-CSF GAAACCGTAGACGTCGTCTG GTGCTGCTCATAGTGCTTGG 62 150 DQ108393 [21]
HPRT1 GGACTTGAATCATGTTTGTG CAGATGTTTCCAAACTCAAC 60 91 DQ815175 [24]
IL1a CCCGTCAGGTCAATACCTC GCAACACGGGTTCGTCTTC 60 170 NM 214029 [43]
IL6 ATCAGGAGACCTGCTTGATG TGGTGGCTTTGTCTGGATTC 62 177 NM_214399 [43]
CXCL8 TCCTGCTTTCTGCAGCTCTC GGGTGGAAAGGTGTGGAATG 62 100 NM_213867 [21]
IL10 GGTTGCCAAGCCTTGTCAG AGGCACTCTTCACCTCCTC 60 202 NM_214041 [22]
RPL19 AACTCCCGTCAGCAGATCC AGTACCCTTCCGCTTACCG 60 147 AF435591 [21]
TBP-1 AACAGTTCAGTAGTTATGAGCCAGA AGATGTTCTCAAACGCTTCG 60 153 DQ845178 [24]
TGFb GAAGCGCATCGAGGCCATTC GGCTCCGGTTCGACACTTTC 64 162 NM 214015 [21]
TLR4 TGTGCGTGTGAACACCAGAC AGGTGGCGTTCCTGAAACTC 62 136 NM_001113039 [21]
TLR2 ACGGACTGTGGTGCATGAAG GGACACGAAAGCGTCATAGC 62 101 NM_213761 [21]
TNFa CCAATGGCAGAGTGGGTATG TGAAGAGGACCTGGGAGTAG 62 116 X54859 [21]
Reference genes are underlined
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treatments) with Duncann post-test grouping for analy-
sis. The P value ≤ 0.05 was considered to be significant.
Results
Bacterial adhesion
Adherence of ETEC on cell membrane of IPI-2I cells was
measured to assess the ability of Scb and bGM to block
ETEC fimbriae, inhibiting ETEC colonization of the
intestinal tract. The adherence of ETEC K88 GN1034
(~5 × 10
6-1 × 10
7 CFU) on pig intestinal IPI-2I cell line
(~1 × 10
6 cells/well), was approximately 15% (data not
shown). Presence of Scb (MOI = 3, Figure 1a) or bGM
(10 μg/mL, Figure 1b) significantly inhibited ETEC
attachment to 80% of control (p < 0.001) (Figure 1).
These optimal doses of Scb or bGM were chosen for the
following assays.
Cytokine and chemokine mRNA expression of IPI-2I cells
To assess the preventive effect of Scb and bGM on the
early immune response to ETEC, we studied the mRNA
expression of several cytokines and chemokines. We
also verified that Scb and bGM did not induce
proinflammatory effect per se compared to control cells
(Figure 2). As shown in Figure 2, IPI-2I cells cultured
with ETEC showed a large up-regulation in the mRNA
expression of genes related to inflammation cytokines
a n dc h e m o k i n e sc o m p a r e dt ot h ec o n t r o lg r o u p( p <
0.001). The bacterial challenge induced up to 20-fold
increase in Tumor Necrosis Factor-a (TNFa)m R N A
levels (p < 0.001) and 10-fold higher for chemokine
(C-C motif) ligand 20 (CCL20, p < 0.001), whereas the
increase was of lower magnitude, between 3- and 6- fold
(p < 0.001, Figure 2) for Granulocyte/Macrophage Col-
ony-Stimulating Factor (GM-CSF), CCL2, CXCL2, inter-
leukins-1a, IL6 and chemokine (C-X-C motif) ligand -2
(CXCL2) and -8 (CXCL8).
The addition of Scb on IPI-2I cells induced a 50%
inhibition of the ETEC-induced mRNA expression of
TNFa,G M - C S Fa n dC C L 2 0( p < 0.01) (Figure 2).
Furthermore, Scb reduced the ETEC-induced mRNA
expression for IL1a,I L 6 ,C C L 2a n dC X C L 8g e n e st o
unchallenged control level (Figure 2). Similar to Scb,
addition of bGM (10 μg/mL) down-regulated the
ETEC-induced mRNA expression of TNFa,G M - C S F ,
CCL2, IL6 and CCL20 in infected cells (p <0 . 0 1 ) .I n h i -
bition of CXCL8 was smaller in bGM treated cells
(×1.5, p < 0.05, Figure 2) compared to Scb (×4).
Finally, bGM did not inhibit IL1a ETEC-induced
mRNA.
Cytokine and chemokine secretion
To confirm the results for the mRNA expression, we
studied the protein secretion of cytokine IL6 and che-
mokine CXCL8 by ELISA at 24 h after the infection.
Similarly to the mRNA data, neither Scb nor bGM
showed proinflammatory effects per se and ETEC infec-
tion caused a 3.8-fold up-regulation for IL6 concentra-
tion (p < 0.01) (Figure 3a) and a 1.8-fold increase for
CXL8 compared to control wells (p <0 . 0 1 )( F i g u r e3 b ) .
Addition of Scb or bGM induced between 4- to 10- fold
reduction for IL6 (Figure 3a) and a 1.4-fold decrease for
CXCL8 (Figure 3b) (p < 0.05) without any statistical dif-
ference between both products.
Modulation of mRNA expression of monocyte derived
dendritic cells
Effects of Scb and bGM on DCs activation or matura-
tion were determined by the exposure of these products
to porcine monocyte-derived DCs with and without
ETEC co-culture. The highest pathogen induced DC
activation by ETEC was obtained at MOI = 5, previously
determined by proinflammatory gene expression
(mRNA) after 3 h of co-culture (data not shown). Our
results showed that ETEC induced a 2.6 fold-increase of
mRNA level of CCR7 and a 4.6 fold up-regulation for
TNFa compared to control DC (Figure 4, p < 0.01).
Figure 1 Adherence of ETEC on pig intestinal IPI-2I cells in the
presence of Scb or bGM. Attachment of ETEC on IPI-2I cells co-
cultured with Scb (A) or bGM (B) is inhibited in a dose-dependent
manner. Data are presented as mean percentage ± S.D (n =5 )
representative of 3 independent assays. Means with different
superscripts (a, b, c) are significantly different (p < 0.05).
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(BAFF), a proliferation-inducing ligand (APRIL) and
CCL17 were between 1.5 and 2 fold-higher in ETEC-
induced DCs than in unchallenged DCs (Figure 4, p <
0.01). The mRNA level for IL6 and GM-CSF were
highly up-regulated (×13 and ×26 respectively) after
ETEC co-culture, as well as for IL10 (×6) (Figure 4, p <
0.001). Therefore, we defined activated DC as high
mRNA expression of CCR7 and TLR4 receptors, T-cell-
independent IgA class-switch recombination (CSR)
modulatory factors BAFF and APRIL; cytokines TNFa,
IL6, GM-CSF, CCL17 and IL10.
The mere addition of Scb (MOI = 3) or bGM (10 μg/
mL) triggered a slight but statistically significant up-reg-
ulation of TNFa (×2.7 and ×2 respectively) and CCR7
mRNA (×1.6) compared to the control with medium
(Figure 4, p < 0.05). Both products also enhanced gene
expression for GM-CSF (×5 and ×1.6). However, only
Scb induced gene expression of IL6 (×3.3) and IL10
(×2.3) (Figure 4, p < 0.05).
Figure 2 Effects of Scb and bGM on cytokine and chemokine mRNA expression in IPI-2I cells cultured with ETEC. IPI-2I cells (1 × 10
6
cells/well) were co-cultured with Scb (3 yeast/cell) or bGM (10 μg/mL) with ETEC (1 × 10
7 CFU/well) for 3 h. Data are presented as means of
mRNA relative expressions ± SD (n = 6). Results are representative of 3 independent experiments. Means with different superscripts (a, b, c, d, e)
are significantly different (p < 0.0.5).
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tured with Scb (MOI = 3) or bGM (10 μg/mL) was simi-
lar to infected control (Figure 4) for TNFa, CCR7,
T L R 4 ,T L R 2 ,B A F F ,A P R I La n dT G F b genes. Therefore
no synergistic or antagonistic effect was observed for
these genes related to DCs activation. However, ETEC-
induced mRNA expression of IL10 and CCL17 was 2.3-
fold inhibited in bGM treated DCs (p< 0.05, Figure 4).
Discussion
After European ban of antibiotic growth promoters for
animal feeding (EC 1831/2003), probiotics and prebiotics
have been postulated as promising alternatives to AGPs
in animal feeding [7]. This work studied the effect of a
new commercial prebiotic compared to an already pro-
ven probiotic on porcine IECs and DCs in the context of
an ETEC in vitro infection. Besides to provide selective
advantages to microbiota and to exclude pathogens, pre-
biotics are believed to mimic the host cell receptor which
the pathogen adheres. Mannose derivates are described
to bind to Type I fimbriae or pili which contains multi-
ple-subunits of lectins that bind to mannan units of the
glycoproteins on the surface of host cells [27,28]. In that
sense, Shoaf et al. [3], tested several commercially avail-
able non-digestible oligosaccharides (NDOs) with differ-
ent molecular structures. The latter highlighted that
galactoligosaccharides had higher inhibition of E.coli
adherence on Caco-2 and Hep-2 cells in a dose depen-
dent manner. Similar to NDOs, yeast probiotic proper-
ties, such as Saccharomyces cerevisiae,a r es p e c i e -o r
strain- specific [29]. The ability of Scb to aggregate enter-
ohaemorrhagic E.coli (EHEC) on their cell wall though
type I fimbriae recognition was described by Gedek B. R
[30]. However, ETEC K88 bears F4 fimbriae [31], which
is described as mannose-resistant in the agglutination
test with 0.5% D-mannose [32]. Nevertheless, all three
variants of K88 adhesin expressed on the tip of the F4
fimbriae recognize carbohydrate structures expressed on
host cell glycoconjugates [33] such as sialoglycoproteins,
intestinal mucin-type glycoproteins and neutral glyco-
sphingolipids [34]. Indeed, b-linked galactose residues
have been found to be essential component in the attach-
ment of K88 fimbriae to mucus K88 receptors [35,36].
Our results show that addition of Scb or bGM, reduces
the adhesion of ETEC on the surface of porcine intestinal
epithelial IPI-2I cell approximately to 80%. Together,
these data confirm that products highly rich in galactose
residues, like our bGM and Scb, may bind to K88 adhesin
[27], suggesting their role as a prophylactic agent to gas-
trointestinal infections in pigs [37,38].
The enterotoxigenic E.coli K88 (ETEC) in vitro infec-
tion causes a proinflammatory transcriptional profile on
porcine intestinal cells IPI-2I, upregulating gene expres-
sion cytokines TNFa, GM-CSF involved in proliferation
and activation of neutrophils, IL1a, IL6 (acute phase
reactions, proliferation and differentiation of macro-
phages and B-cells) as well as proinflammatory chemo-
kines CXCL8 (neutrophil recruitment), CCL2 (MCP-1,
Monocyte chemotactic protein-1), CXCL2 and CCL20
chemotactic for immature DCs involved in the bacterial
uptake across the epithelial barrier. These results are in
accordance to results of Eckmann et al., [39], but con-
t r a r yt od a t ap u b l i s h e db yP a v l o v ae ta l . ,[ 4 ]w h of o u n d
no differences in mRNA expression of cytokine TNFa
and chemokine CXCL8 after in vitro attachment of dif-
ferent serotypes of ETEC on IPI-2I cells. However,
response of IPI-2I cells under challenge conditions and
mRNA expression of genes TNFa and CXCL8 has been
already demonstrated in the gene expression study per-
formed by Mariani et al., [40], as well as in different host-
pathogen interaction studies where IPI-2I were infected
by another Gram negative pathogen as Salmonella [41];
Salmonella lipopolysaccharide (LPS) [42] or even Entea-
moeba hystolytica parasite [43]. The explanation for
these contradictory results may be due the difference in
cell culture conditions (see M a r i a n ie ta l . ,[ 4 0 ] )o rt ot h e
Figure 3 Effect of Scb and bGM on IL6 and CXCL8 secretion
induced by ETEC. Cytokine IL6 (A) and chemokine CXCL8 (B)
concentration in supernatants from IPI-2I cells (1 × 10
6 cells/well)
co-cultured for 24 h with ETEC (1 × 10
7 CFU/well) is decreased by
Scb (3 yeast/cell) or bGM (10 μg/mL). Data were presented as mean
± S.D (n = 6). Data are representative of 3 independent
experiments. Means with different superscripts (a, b, c, d) are
significantly different (p < 0.05).
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our model, presence of ETEC or their bacterial constitu-
ents such as LPS or flagellin induces a two to tenfold
increase in mRNA expression of proinflammatory genes
in IPI-2I cells compared to the non-infected cells. At the
protein level, data for IL6 and CXCL8 in infected IPI-2I
cells (Figure 3) are comparable to protein secretion of pig
intestinal IPEC-J2 cells shown by Devriendt et al. [31], as
a response of TLR5 signalling cascade upon recognition
of ETEC F4 flagellin. Addition of Scb or bGM down-reg-
ulate ETEC-induced gene expression of TNFa, GM-CSF,
IL6, CCL2, CXCL2 and CCL20, reducing the overall
proinflammatory state caused by ETEC. This effect is not
induced for mRNA of IL1a nor CXCL8 in bGM treated
cells compared to the Scb treatment, but no difference
was shown between IL6 and CXCL8 in the reduction of
mRNA or protein expression.
In accordance to current data, probiotic Scb has been
shown to secrete anti-inflammatory factors smaller than
10 kDa [44] that have inhibitory effects on mRNA
expression of cytokine IL1-a, IL6 as well as chemokines
CXCL2 and CXCL8 on IPI-2I cells co-cultured with
ETEC [18]. These anti-inflammatory properties have
been related to direct blocking of nuclear factor-kappa B
(NFkB) and mitogen associated protein kinase (MAPK)
activation [45] or by indirect neutralization of ETEC
toxins [8]. Recently, Zanello et al. [46] demonstrated
that Saccharomyces cerevisiae inhibition on proinflam-
matory transcripts in porcine intestinal cells IPEC-1 co-
cultured with ETEC was associated to the decrease of
ERK1/2 and p38 MAPK phosphorylation. Related to
NDOs, beneficial role of bGM from partially hydrolyzed
guar gum was described to prevent mucosal damage in
dextran sulphate sodium (DSS) induced colitis in mice
Figure 4 ETEC-induced gene expression in porcine DCs co-cultured with Scb or bGM. Relative mRNA expression of proinflammatory
cytokines (TNFa, GM-CSF, IL6, IL10), chemokines (CXCL8, CCL17), receptors (CCR7, TLR2, TLR4) and regulatory factors (APRIL, BAFF, TGFb) in DCs
is enhanced by ETEC. Data were presented as mean ± S.D (n = 6). Treatments with different letters (a, b, c, d) mean p < 0.05.
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Page 8 of 11[47] by a decrease of TNFa mRNA/protein and neutro-
phil infiltration. Future studies should determine the
role of NDOs and especially bGM on the molecular sig-
naling pathways involved in regulation of IECs upon
ETEC infection.
Probiotics and prebiotics are believed to be recognized
by PRRs expressed on dendritic cells (DCs) located in
the subepithelial dome (SED) and/or to extend their
dendrites between epithelial cells to the lumen. We
aimed to establish if optimal concentrations of Scb or
bGM for IECs also modulate DC activation or matura-
tion per se and/or under ETEC infection. In our work,
brief incubation (3 h) with Scb or bGM induced a
slightly activation of DC observed by an up-regulation
of mRNA for TNFa and CCR7 coreceptor (Figure 4).
Recently, Santander et al. [48] described that long expo-
sure (~48 h) to bGM from Caesalpinia spinosa plant
extracts induce phenotypic maturation of human DC
characterized by CD83, CD86, CD206 and HLA-DR and
increase mRNA for IL1b, IL6, CXCL8 and IL12p70
cytokines.
The ETEC-induced maturation of porcine DCs is
mainly induced by flagellin, through Fcg receptor liga-
tion [49], among other bacterial constituents such as F4
and LPS [49,50]. We observed that ETEC up-regulated
mRNA level of CCR7, receptor for CCL19 and CCL21,
which provides DC signal for entry into the inductive
sites of the adaptive immune system such as the lymph
node. Furthermore, there was an increase in BAFF and
APRIL, members of the tumor necrosis factor superfam-
ily involved in T-cell-independent IgA class-switch
recombination (CSR). Additionally, ETEC recognition by
TLR4 induced up-regulation of this receptor and acti-
vated the gene expression of cytokines TNFa,G M - C S F ,
CCL17 and IL6. Finally, IL10 mRNA was increased in
challenged DCs, probably to limit over-whelming speci-
fic and unspecific immune response and to avoid tissue
damage [51]. Although no phenotypic study was per-
formed in this work, published data [50] indicate that
porcine monocyte-derived DC are expected to increase
cell surface co-stimulatory molecules CD80/C86 and
protein TNFa, IL6 and CXCL8 secretion after TLR
ligand recognition.
In our study, co-incubation of porcine DCs with Scb
or bGM and ETEC did not trigger significant differences
on DCs maturation compared to infected control for the
most of the genes studied. In contrast, Sonck et al. [52]
found that effects of b-glucans on DC maturation differ
according to their origin, while Saccharomyces cerevisiae
derived b-glucan Macrogard induced mature phenotype
determined by upregulation of DC activation markers
(CD80/86, CD40 and MHC class II), curdlan enhanced
expression of cytokines IL-1b, IL-6, IL-10 and IL-12/IL-
23p40. Related to prebiotics, Wismar et al. [53] found
that galactomannans from guar gum at high concentra-
tions (~200 μg/mL) directly stimulate mice DCs and
modulate DC maturation induced by microbial signals,
such as LPS, leading to a synergistically increased TNFa
and IL10 proteins and suppression of IL-12p70. Indeed,
Sheng et al. [54] showed that mannan and mannan asso-
ciated structures activate TLR4 signalling pathways in a
dose dependent manner, induce DCs mature phenotype
(CD40, CD80 and CD86) and up-regulate proinflamma-
tory mRNA for IL1-b and TNFa c y t o k i n e sa sw e l la s
other Th1/Th2 cytokines. Considering that origin, struc-
ture and size of mannans or b-glucans is crucial to
determine their immune regulatory role [53], differences
in product concentration and time exposure may
explain our contrary results.
The beneficial role of these products remains to be
elucidated on DCs activation under ETEC infection, as
well as for other cell types involved in the mucosal
immune response, such as monocytes/macrophages or
neutrophils. In addition to evaluate Scb and bGM in in
vivo trials, research approaches as three-dimensional co-
culture [55] or gut-loop intestinal models [21] may
determine effect of Scb and bGM on the cross-talk of
IECs, DCs and other cell types under ETEC infection.
To summarize, present findings describe the protective
role of probiotic Saccharomyces cerevisiae var. Boulardii
and a recently developed prebiotic b-galactomannan, to
prevent E.coli K88 infection using an in vitro model for
pig intestinal cells, and consequently their ability to reduce
pathogenic inflammation. These results may lead to in
vivo trials to assess the suitability of probiotic Scb and pre-
biotic bGM as alternative to antibiotics growth promoters
in animal production.
List of abbreviations
APRIL: A proliferation-inducing ligand; BAFF: B-cell activating factor; βGM: β-
galactomannan; CCL: chemokine: C-C motif) ligand; CXCL: chemokine: C-X-C
motif) ligand; DCs: Dendritic cells; ETEC: Enterotoxigenic Escherichia coli K88;
GM-CSF: Granulocyte/Macrophage Colony-Stimulating Factor; IECs: Intestinal
epithelial cells; IL: Interleukin; NDOs: Non-digestible oligosaccharides; PAMPs:
Pathogen associated molecular patterns; PRRs: Pattern recognition receptors;
Scb (Saccharomyces cerevisiae var. Boulardii; TLR: Toll like receptor; TNFα:
Tumor necrosis factor-α).
Acknowledgements
This work was supported by grants from the French National Institute for
Agricultural Research (INRA, France) and grant AGL 2009-11936 of the
Ministerio de Ciencia e Innovación (MICIIN, Spain). We gratefully
acknowledge Dr I. Badiola (CReSA) for providing ETEC GN1034 strain and Dr
J. Domínguez-Juncal (Instituto Nacional de Investigación y Tecnología
Agraria y Alimentaria, INIA, Madrid, Spain) for kindly providing antibodies for
pig cell surface markers.
Author details
1Institut de Recerca i Tecnologia Agroalimentàries, Animal Production, IRTA,
Constantí, Spain.
2Institut National de la Recherche Agronomique (INRA),
UR1282, Infectiologie Animale et Santé Publique, F-37380 Nouzilly, Tours,
France.
3Immunologia Aplicada, Institut de Biotecnologia i de Biomedicina
(IBB), University Autonomous of Barcelona, UAB, Bellaterra, Spain.
Badia et al. Veterinary Research 2012, 43:4
http://www.veterinaryresearch.org/content/43/1/4
Page 9 of 11Authors’ contributions
RB conceived the study and carried out IECs and DCs host cell-pathogen co-
cultures, molecular studies and immunoassays. GZ participated in IECs host
cell-pathogen assays and molecular analysis. CC worked in DCs
differentiation and co-culture. RL participated in experimental design and
statistical analysis. PM, FM, JB and HS equally conceived, coordinated the
study and helped to draft the manuscript. All authors read and approved
the final manuscript.
Competing interests
JB is one of the inventors of the patent Salmosan
®® WO2009/144070 A2
commercially licensed to Industrial Técnica Pecuaria (ITPSA, Barcelona, Spain).
This does not alter the author’s adherence to all the Veterinary Research
policies on data collection and analysis, preparation of the manuscript or
sharing data and materials. Other authors declare that they have no
competing interests.
Received: 21 June 2011 Accepted: 25 January 2012
Published: 25 January 2012
Nagy B, Arp LH, Moon HW, Casey TA: Colonization of the small intestine
of weaned pigs by enterotoxigenic Escherichia coli that lack known colo-
nization factors. Vet Pathol 1992, 29:239-246.
2. Girard MP, Steele D, Chaignat CL, Kieny MP: A review of vaccine research
and development: human enteric infections. Vaccine 2006, 24:2732-2750.
3. Shoaf K, Mulvey GL, Armstrong GD, Hutkins RW: Prebiotic
galactooligosaccharides reduce adherence of enteropathogenic
Escherichia coli to tissue culture cells. Infect Immun 2006, 74:6920-6928.
4. Pavlova B, Volf J, Alexa P, Rychlik I, Matiasovic J, Faldyna M: Cytokine mRNA
expression in porcine cell lines stimulated by enterotoxigenic Escherichia
coli. Vet Microbiol 2008, 132:105-110.
5. World Health Organisation: The Medical Impact of the use of
antimicrobials in food animals. 13-17 October; Berlin, Germany 1997.
6. Brufau J: Animal feeding in Europe: challenges and opportunities. In
Nutritional biotechnology in the feed and food industries. Edited by: Lyons TP,
Jacques KA. Notthingham University Press; 2003:.
7. Gaggìa F, Mattarelli P, Biavati B: Probiotics and prebiotics in animal
feeding for safe food production. Int J Food Microbiol 2010, 141(Suppl 1):
S15-28.
8. Zanello G, Meurens F, Berri M, Salmon H: Saccharomyces boulardii effects
on gastrointestinal diseases. Curr Issues Mol Biol 2009, 11:47-58.
9. Morales-López R, Auclair E, García F, Esteve-Garcia E, Brufau J: Use of yeast
cell walls; beta-1, 3/1, 6-glucans; and mannoproteins in broiler chicken
diets. Poult Sci 2009, 88:601-607.
10. Czerucka D, Piche T, Rampal P: Review article: yeast as probiotics –
Saccharomyces boulardii. Aliment Pharmacol Ther 2007, 26:767-778.
11. Oswald IP: Role of intestinal epithelial cells in the innate immune
defence of the pig intestine. Vet Res 2006, 37:359-368.
12. Summerfield A, McCullough KC: The porcine dendritic cell family. Dev
Comp Immunol 2009, 33:299-309.
13. Artis D: Epithelial-cell recognition of commensal bacteria and
maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008,
8:411-420.
14. Sansonetti PJ: War and peace at mucosal surfaces. Nat Rev Immunol 2004,
4:953-964.
15. Cloeckaert A, Schwarz S: Molecular characterization, spread and evolution
of multidrug resistance in Salmonella enterica typhimurium DT104. Vet
Res 2001, 32:301-310.
16. Kaeffer B, Bottreau E, Velge P, Pardon P: Epithelioid and fibroblastic cell
lines derived from the ileum of an adult histocompatible miniature boar
(d/d haplotype) and immortalized by SV40 plasmid. Eur J Cell Biol 1993,
62:152-162.
17. Warrand J: Healthy polysaccharides. Food Technol Biotech 2006, 44:355-370.
18. Zanello G, Meurens F, Berri M, Chevaleyre C, Melo S, Auclair E, Salmon H:
Saccharomyces cerevisiae decreases inflammatory responses induced by
F4+ enterotoxigenic Escherichia coli in porcine intestinal epithelial cells.
Vet Immunol Immunopathol 2011, 141:133-138.
19. Elsinghorst EA: Measurement of invasion by gentamicin resistance.
Methods Enzymol 1994, 236:405-420.
20. Bruel T, Guibon R, Melo S, Guillén N, Salmon H, Girard-Misguich F,
Meurens F: Epithelial induction of porcine suppressor of cytokine
signaling 2 (SOCS2) gene expression in response to Entamoeba
histolytica. Dev Comp Immunol 2010, 34:562-571.
21. Meurens F, Berri M, Auray G, Melo S, Levast B, Virlogeux-Payant I,
Chevaleyre C, Gerdts V, Salmon H: Early immune response following
Salmonella enterica subspecies enterica serovar Typhimurium infection in
porcine jejunal gut loops. Vet Res 2009, 40:5.
22. Levast B, de Monte M, Chevaleyre C, Melo S, Berri M, Mangin F, Zanello G,
Lantier I, Salmon H, Meurens F: Ultra-early weaning in piglets results in
low serum IgA concentration and IL17 mRNA expression. Vet Immunol
Immunopathol 2010, 137:261-268.
23. Meurens F, Berri M, Siggers RH, Willing BP, Salmon H, Van Kessel AG,
Gerdts V: Commensal bacteria and expression of two major intestinal
chemokines, TECK/CCL25 and MEC/CCL28, and their receptors. PLoS One
2007, 2:e677.
24. Nygard AB, Jørgensen CB, Cirera S, Fredholm M: Selection of reference
genes for gene expression studies in pig tissues using SYBR green qPCR.
BMC Mol Biol 2007, 8:67.
25. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A,
Speleman F: Accurate normalization of real-time quantitative RT-PCR
data by geometric averaging of multiple internal control genes. Genome
Biol 2002, 3, RESEARCH0034.
26. Pilon C, Meurens F, Dauba A, Salmon H, Velge-Roussel F, Lebranchu Y,
Baron C: Induction of porcine regulatory cells by mycophenolic Acid-
treated dendritic cells. Transplant Proc 2009, 41:700-702.
27. Sharon N: Carbohydrates as future anti-adhesion drugs for infectious
diseases. Biochim Biophys Acta 2006, 1760:527-537.
28. Althouse C, Patterson S, Fedorka-Cray P, Isaacson RE: Type 1 fimbriae of
Salmonella enterica serovar Typhimurium bind to enterocytes and
contribute to colonization of swine in vivo. Infect Immun 2003,
71:6446-6452.
29. van der Aa Kühle A, Skovgaard K, Jespersen L: In vitro screening of
probiotic properties of Saccharomyces cerevisiae var. boulardii and food-
borne Saccharomyces cerevisiae strains. Int J Food Microbiol 2005,
101:29-39.
30. Gedek BR: Adherence of Escherichia coli serogroup O 157 and the
Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces
boulardii. Mycoses 1999, 42:261-264.
31. Devriendt B, Stuyven E, Verdonck F, Goddeeris BM, Cox E: Enterotoxigenic
Escherichia coli (K88) induce proinflammatory responses in porcine
intestinal epithelial cells. Dev Comp Immunol 2010, 34:1175-1182.
32. Nagy B, Fekete PZ: Enterotoxigenic Escherichia coli in veterinary medicine.
Int J Med Microbiol 2005, 295:443-454.
33. Jin LZ, Zhao X: Intestinal receptors for adhesive fimbriae of
enterotoxigenic Escherichia coli (ETEC) K88 in swine–a review. Appl
Microbiol Biotechnol 2000, 54:311-318.
34. Sarabia-Sainz AI, Ramos-Clamont G, Candia-Plata MM, Vázquez-Moreno L:
Biorecognition of Escherichia coli K88 adhesin for glycated porcine
albumin. Int J Biol Macromol 2009, 44:175-181.
35. Payne D, O’Reilly M, Williamson D: The K88 fimbrial adhesin of
enterotoxigenic Escherichia coli binds to beta 1-linked galactosyl
residues in glycosphingolipids. Infect Immun 1993, 61:3673-3677.
36. Grange PA, Mouricout MA, Levery SB, Francis DH, Erickson AK: Evaluation
of receptor binding specificity of Escherichia coli K88 (F4) fimbrial
adhesin variants using porcine serum transferrin and glycosphingolipids
as model receptors. Infect Immun 2002, 70:2336-2343.
37. Becker PM, Galletti S: Food and feed components for gut health-
promoting adhesion of E. coli and Salmonella enterica. J Sci Food Agric
2008, 88:2026-2035.
38. White LA, Newman MC, Cromwell GL, Lindemann MD: Brewers dried yeast
as a source of mannan oligosaccharides for weanling pigs. J Anim Sci
2002, 80:2619-2628.
39. Eckmann L, Kagnoff MF: Intestinal mucosal responses to microbial
infection. Springer Semin Immunopathol 2005, 27:181-196.
40. Mariani V, Palermo S, Fiorentini S, Lanubile A, Giuffra E: Gene expression
study of two widely used pig intestinal epithelial cell lines: IPEC-J2 and
IPI-2I. Vet Immunol Immunopathol 2009, 131:278-284.
41. Volf J, Boyen F, Faldyna M, Pavlova B, Navratilova J, Rychlik I: Cytokine
response of porcine cell lines to Salmonella enterica serovar
typhimurium and its hilA and ssrA mutants. Zoonoses Public Health 2007,
54:286-293.
Badia et al. Veterinary Research 2012, 43:4
http://www.veterinaryresearch.org/content/43/1/4
Page 10 of 1142. Arce C, Ramírez-Boo M, Lucena C, Garrido JJ: Innate immune activation of
swine intestinal epithelial cell lines (IPEC-J2 and IPI-2I) in response to
LPS from Salmonella typhimurium. Comp Immunol Microbiol Infect Dis
2010, 33:161-174.
43. Meurens F, Girard-Misguich F, Melo S, Grave A, Salmon H, Guillén N: Broad
early immune response of porcine epithelial jejunal IPI-2I cells to
Entamoeba histolytica. Mol Immunol 2009, 46:927-936.
44. Sougioultzis S, Simeonidis S, Bhaskar KR, Chen X, Anton PM, Keates S,
Pothoulakis C, Kelly CP: Saccharomyces boulardii produces a soluble anti-
inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene
expression. Biochem Biophys Res Commun 2006, 343:69-76.
45. Pothoulakis C: Review article: anti-inflammatory mechanisms of action of
Saccharomyces boulardii. Aliment Pharmacol Ther 2009, 30:826-833.
46. Zanello G, Berri M, Dupont J, Sizaret PY, D’Inca R, Salmon H, Meurens F:
Saccharomyces cerevisiae modulates immune gene expressions and
inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal
epithelial cells. PLoS One 2011, 6:e18573.
47. Naito Y, Takagi T, Katada K, Uchiyama K, Kuroda M, Kokura S, Ichikawa H,
Watabe J, Yoshida N, Okanoue T, Yoshikawa T: Partially hydrolyzed guar
gum down-regulates colonic inflammatory response in dextran sulfate
sodium-induced colitis in mice. J Nutr Biochem 2006, 17:402-409.
48. Santander SP, Aoki M, Hernandez JF, Pombo M, Moins-Teisserenc H,
Mooney N, Fiorentino S: Galactomannan from Caesalpinia spinosa
induces phenotypic and functional maturation of human dendritic cells.
Int Immunopharmacol 2011, 11:652-660.
49. Devriendt B, Verdonck F, Summerfield A, Goddeeris BM, Cox E: Targeting of
Escherichia coli F4 fimbriae to Fcgamma receptors enhances the
maturation of porcine dendritic cells. Vet Immunol Immunopathol 2010,
135:188-198.
50. Auray G, Facci MR, van Kessel J, Buchanan R, Babiuk LA, Gerdts V:
Differential activation and maturation of two porcine DC populations
following TLR ligand stimulation. Mol Immunol 2010, 47:2103-2111.
51. Couper KN, Blount DG, Riley EM: IL-10: the master regulator of immunity
to infection. J Immunol 2008, 180:5771-5777.
52. Sonck E, Devriendt B, Goddeeris B, Cox E: Varying effects of different β-
glucans on the maturation of porcine monocyte-derived dendritic cells.
Clin Vaccine Immunol 2011, 18:1441-1446.
53. Wismar R, Brix S, Laerke HN, Frøkiaer H: Comparative analysis of a large
panel of non-starch polysaccharides reveals structures with selective
regulatory properties in dendritic cells. Mol Nutr Food Res 2011,
55:443-454.
54. Sheng KC, Pouniotis DS, Wright MD, Tang CK, Lazoura E, Pietersz GA,
Apostolopoulos V: Mannan derivatives induce phenotypic and functional
maturation of mouse dendritic cells. Immunology 2006, 118:372-383.
55. Zoumpopoulou G, Tsakalidou E, Dewulf J, Pot B, Grangette C: Differential
crosstalk between epithelial cells, dendritic cells and bacteria in a co-
culture model. Int J Food Microbiol 2009, 131:40-51.
doi:10.1186/1297-9716-43-4
Cite this article as: Badia et al.: Effect of Saccharomyces cerevisiae var.
Boulardii and b-galactomannan oligosaccharide on porcine intestinal
epithelial and dendritic cells challenged in vitro with Escherichia coli F4
(K88). Veterinary Research 2012 43:4.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Badia et al. Veterinary Research 2012, 43:4
http://www.veterinaryresearch.org/content/43/1/4
Page 11 of 11